The L-type amino acid transporter 1 (LAT1) was found to promote chemoresistance in ER-positive/HER2-negative breast cancer [69] by facilitating the uptake of other amino acids, which can be used by cells for energy production and biomass synthesis, supporting the growth of cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.